Why the study?
Does peak oxygen uptake (VO2) predict survival in patients with inoperable chronic thromboembolic pulmonary hypertension?
Does peak oxygen uptake (VO2) predict survival in patients with inoperable chronic thromboembolic pulmonary hypertension?
Peak VO2 predicts survival in inoperable CTEPH when adjusting for age, gender, and PVR, but loses independent prognostic value when all significant baseline variables are included.
Peak VO2 threshold may aid univariate survival stratification in inoperable CTEPH; leaves open independent value after full multivariate adjustment.
Background Patients with chronic thromboembolic pulmonary hypertension (CTEPH) present with a decreased oxygen uptake, however, the prognostic relevance of oxygen uptake (VO 2 ) in inoperable CTEPH is unknown. Methods Patients with inoperable CTEPH were retrospectively analyzed. All patients were assessed by means of right heart catheterisation and cardio pulmonary exercise testing in semisupine position with a 30 Watt increment step‐protocol. Results One‐hundred and fifty‐one patients (82 female (54.3%), mean age 61 ± 12.4 years) presented with a mean pulmonary arterial pressure of 40.2 ± 14.2 mmHg and pulmonary vascular resistance (PVR) of 641.9 ± 374.8 dyne∗s/cm 5 . The peak VO 2 (mean 13.1 ± 4.5 mL∗kg −1 ∗min −1 ) was measured at initial referral. Over a follow‐up of up to 10 years (mean 4.41 ± 2.57 years), 31 patients had died. Patients with a baseline peak VO 2 ≥ 10.7 mL∗kg −1 ∗min −1 [area under the receiver‐operating characteristic curve (AUC) = 0.728, P = 0.001] had better survival than those with a peak VO 2 ≤ 10.7 mL∗kg −1 ∗min −1 using Kaplan–Meier analysis (88.8% vs 60.1%; log rank P = 0.001). Adjusting for age, gender and PVR, multivariate analysis identified peak VO 2 as a predictor of mortality [hazard ratio (HR): 2.78, 95% CI 1.01–7.63, P = 0.047]. In addition, peak VO 2 failed as an independent prognostic factor in a stepwise multivariate model including all variables significant in the univariate analysis. Conclusions In patients with inoperable CTEPH the peak VO 2 is a significant predictor of survival, when adjusting for age, gender and PVR. However, peak VO 2 failed as an independent prognostic factor when correcting for all significant baseline variables, which is limiting the clinical usability.
No takes yet. Share an insight, caveat, or question.
Richter et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: